Institutional & Family Asset Management’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$59.5K Hold
2024
Q1
$87.2K Sell
2023
Q4
$132K Hold
2023
Q3
$121K Hold
2023
Q2
$159K Buy
2023
Q1
$65.9K Hold
2022
Q4
$88.4K Hold
2022
Q3
$105K Buy
2022
Q2
$113K Hold
2022
Q1
$294K Hold
2021
Q4
$610K Buy
2021
Q3
$50K Buy